Table 1.
Characteristic | Overall N=17,044 (%) |
---|---|
Age (years) | |
18-29 | 2,560 (15%) |
30-39 | 4,261 (25%) |
40-49 | 5,826 (34%) |
50-59 | 3,259 (19%) |
≥ 60 | 1,138 (7%) |
Sex | |
Male | 13,764 (81%) |
Female | 3,289 (19%) |
Race/Ethnicity | |
White | 6,244 (37%) |
Black | 7,101(42%) |
Hispanic | 2,143 (13%) |
Unknown | 1,364 (8%) |
HIV Risk Factor | |
MSM | 6,789 (40%) |
Heterosexual | 4,591 (27%) |
IDU | 1,850 (11%) |
Unknown | 3,409 (22%) |
First CD4 Count in Year | |
< 350 cell/mm3 | 7,511 (44%) |
350-499 cell/mm3 | 3,669 (22%) |
≥500 cell/mm3 | 4,321 (25%) |
Missing | 1,534 (9%) |
Use of ART in Year | |
No | 7,590 (45%) |
Yes | 9,454 (55%) |
Calendar Year | |
2006 | 3,719 (22%) |
2007 | 3,510 (21%) |
2008 | 3,611 (21%) |
2009 | 3,346 (20%) |
2010 | 2,858 (16%) |
NHAS Retention Measure | |
Not Retained | 1,846 (11%) |
Retained | 15,198 (89%) |
DHHS Retention Indicator | |
Not Retained | 4,473 (26%) |
Retained | 12,571 (74%) |
6-Month Gap | |
Yes (Not Retained) | 2,563 (15%) |
No (Retained) | 14,481 (85%) |
3-Month Visit Constancy | |
1 | 2,901 (17%) |
2 | 3,586 (21%) |
3 | 4,806 (28%) |
4 | 5,751 (34%) |
Viral Suppression | |
No | 7,119 (42%) |
Yes | 8,259 (48%) |
Missing | 1,666 (10%) |
Abbreviations: ART, antiretroviral therapy; DHHS, Department of Health and Human Services; HET, heterosexual transmission; HIV, human immunodeficiency virus; IDU, injection drug use; MSM, men who have sex with men; NHAS, National HIV/AIDS Strategy.